Pharmafile Logo
Pharmafocus logo
Advanced Search

NICE says yes to Tasigna for resistant disease

January 13, 2012
Sales and Marketing BMS, Glivec, NICE, Novartis, Tasigna

NICE is recommending Novartis’ Tasigna for chronic myeloid leukaemia patients that can no longer use Glivec. In final guidance it …

News

AstraZeneca does data deal

January 13, 2012
Sales and Marketing AstraZeneca, IMS Health, data

AstraZeneca has signed a deal with an information company in a bid to improve the data it has on how …

News

Tracy Baker moves to MSI Consultancy

January 13, 2012
Medical Communications MSI Consultancy

MSI Consultancy has appointed former Novartis manager Tracy Baker as a new consultant. Tracy has over seven years of sales …

Appointment

Novartis to cut 2,000 US jobs

January 13, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Diovan, Novartis, job cuts

Novartis will slash 1,960 jobs in the US as it prepares for life without its blockbuster medicine Diovan. The hypertension …

News

Pharma unprepared for annus horribilis

January 12, 2012
Research and Development, Sales and Marketing AZ, Pfizer, Takeda, patents, pharma

A new survey shows pharma is not prepared to deal with the tough year ahead as many blockbuster drugs begin …

News

Glide Pharma appoints Dr Ian Smith as its new chief executive

January 12, 2012
Business Services, Manufacturing and Production, Sales and Marketing

Glide Pharma, a firm focused on the needle-free administration of solid dose therapeutics and vaccines, has appointed Dr Ian Smith …

Appointment
NICE picture

NICE rejects Sanofi’s Jevtana

January 12, 2012
Sales and Marketing Jevtana, NICE, Sanofi, Zytiga

NICE is not recommending Sanofi’s prostate cancer drug Jevtana due to its high cost and questions over its safety. In …

News

Merck facility reborn as science park

January 11, 2012
Research and Development BioCity, MSD, Merck, Newhouse, Pfizer, Roslin BioCentre, Scotland

A former Merck research site in Scotland has been given a new lease of life as a biotech science park. …

News

NICE guidance to be enforced, says Lansley

January 11, 2012
Sales and Marketing NHS, NICE, PCTs, black lists, prescribing

Local NHS organisations will no longer be allowed to ‘ban’ drugs recommended by NICE, the health secretary has said.England’s primary …

News

Crisis in the boardroom: 2011’s most dramatic departures

January 11, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Actelion, KV pharmaceuticals, Kindler, Pfizer, management

In December 2010, Jeffrey Kindler, the chief executive of Pfizer suddenly announced his departure from the company.His abrupt exit made …

Feature

Janssen signs deal with rising star Forma

January 11, 2012
Research and Development Forma, Janssen, alliance

Janssen has signed a deal with Forma Therapeutics to discover, and develop drugs that target tumour metabolism mechanisms.Forma focuses on …

News

Richard Barker joins Aegate as a senior advisor

January 11, 2012
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, Aegate, Richard Barker

Aegate’s board of directors have announced that the previous director general of the ABPI has joined the company as a …

Appointment
Sanofi picture

Sanofi to collaborate with UCSF on diabetes research

January 11, 2012
Research and Development RNA interference, Sanofi, UCSF, academic alliance, diabetes

The University of California, San Francisco (UCSF) and Sanofi are to launch a new collaboration in diabetes research, focusing on …

News

Allergan plans $350m expansion of Irish plant

January 10, 2012
Manufacturing and Production Allergan, Ireland

Allergan has announced plans to invest $350 million in an expansion of its manufacturing facility in County Mayo, Ireland, a …

News

Underwhelming results for GSK’s Relovair

January 10, 2012
Research and Development, Sales and Marketing Advair, COPD, GSK, Relovair, Seretide, asthma

GlaxoSmithKline says it is on track to file its respiratory drug Relovair in Europe and the US despite mixed results …

News

NICE set to reject Xarelto in AF

January 10, 2012
Sales and Marketing AF, NICE, Pradaxa, Xarelto, atrial fibrillation

NICE says it needs more data on Bayer’s Xarelto in order to recommend it for people with atrial fibrillation. The …

News

USP takes aim at supply chain security for medicines

January 10, 2012
Manufacturing and Production US Pharmacopoeial Convention, USP, supply chains

The US Pharmacopoeial Convention (USP) has published the draft of a new general chapter designed to lay out best practices …

News

Scientists make drug delivery smooth as silk

January 10, 2012
Manufacturing and Production Silk, manufacturing, microneedles

Researchers in the US have developed a new drug delivery system based on silk, which could allow drugs and vaccines …

News

Andrew Roberts joins Apodi senior management team

January 10, 2012
Business Services, Sales and Marketing Andrew Roberts

Apodi has bolstered its senior management team with the arrival of Andrew Roberts as director of Business and Partnership Development. …

Appointment

Study supports GLP-1 agonists for weight loss

January 10, 2012
Research and Development, Sales and Marketing GLP-1, Novo Nordisk, Sanofi, diabetes, lilly

An independent study by academics has concluded that GLP-1 agonist drugs help patients to lose weight – with the effect …

News
The Gateway to Local Adoption Series

Latest content

Alto Neuroscience announces new patent for depression treatment

January 15, 2026

Arkin Capital closes $100m fund for pre-clinical and early clinical-stage biotech

January 15, 2026

Bio-Sourcing and Zerion Pharma receive 1.3m euros in funding for joint breast cancer project

January 14, 2026

Biocartis announces breast cancer research collaboration with US Mayo Clinic

January 14, 2026

Blue Earth announces first UK patient received prostate cancer injection

January 13, 2026